Marksans Pharma Ltd. — Capital/Financing Update 2024

Aug 13, 2024

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

August 13, 2024

BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS

Sub: Statement on Deviation or Variation of funds raised through Preferential Issue of Convertible Warrants.

Dear Sir/Madam,

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMDl/162/2019 dated December 24, 2019, we hereby confirm that there is no deviation or variation in the use of funds raised through Preferential Issue of Convertible Warrants from the objects stated in the Explanatory Statement to the Notice of Extra-Ordinary General Meeting of the Company dated 15[th] June, 2021.

Accordingly, a Nil Statement of Deviation, duly reviewed by the Audit Committee of the Company, for the Quarter ended June 30, 2024 is enclosed as " Annexure A ".

We request you to take the aforesaid in your records.

Thanking You.

Yours faithfully,

For Marksans Pharma Limited

Digitally signed by HARSHAVARDH HARSHAVARDHAN PANIGRAHI AN PANIGRAHI Date: 2024.08.13 18:44:30 +05'30'

Harshavardhan Panigrahi Company Secretary

Encl: As above

==> picture [6 x 74] intentionally omitted <==

==> picture [72 x 15] intentionally omitted <==

==> picture [93 x 15] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

Annexure A